Exelixis, Inc.
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients…
Biotechnology
US, Alameda [HQ]
EXEL/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 151.00 | 185.00 | 289.00 | 47.00 | 31.00 | 25.00 | 37.00 | 191.00 | 452.00 | 853.00 | 967.00 | 987.00 | 1,434.00 | 1,611.00 | 1,830.00 | |
|
EPS
|
-1.26 | -0.85 | 0.60 | -0.92 | -1.33 | -1.38 | -0.81 | -0.28 | 0.52 | 2.32 | 1.06 | 0.36 | 0.73 | 0.57 | 0.65 | |
| Diluted in mil. | -1.26 | -0.85 | 0.58 | -0.92 | -1.33 | -1.38 | -0.81 | -0.28 | 0.49 | 2.21 | 1.02 | 0.35 | 0.72 | 0.56 | 0.65 | |
|
Profit
|
151.00 | 185.00 | 289.00 | 47.00 | 30.00 | 23.00 | 33.00 | 184.00 | 437.00 | 827.00 | 934.00 | 951.00 | 1,382.00 | 1,553.00 | 1,757.00 | |
| Gross Margin | 100.00 | 100.00 | 100.00 | 100.00 | 96.43 | 91.86 | 89.52 | 96.58 | 96.67 | 96.91 | 96.58 | 96.33 | 96.32 | 96.41 | 96.04 | |
| Pre Tax | -140.00 | -92.00 | 76.00 | -147.00 | -244.00 | -268.00 | -169.00 | -70.00 | 158.00 | 452.00 | 398.00 | 130.00 | 294.00 | 234.00 | 257.00 | |
| Profit Margin | -92.81 | -49.93 | 26.58 | -310.93 | -781.34 | -1,070.14 | -456.48 | -36.68 | 35.05 | 52.95 | 41.14 | 13.25 | 20.50 | 14.55 | 14.07 | |
| ETR | 0.91 | 0.08 | 1.68 | -0.07 | 0.04 | 0.07 | -0.03 | -45.65 | 2.74 | -52.64 | 19.37 | 14.56 | 21.45 | 22.22 | 19.32 | |
| Net | -135.00 | -92.00 | 75.00 | -147.00 | -244.00 | -268.00 | -169.00 | -70.00 | 154.00 | 690.00 | 321.00 | 111.00 | 231.00 | 182.00 | 207.00 | |
| Profit Margin | -89.10 | -49.90 | 26.14 | -311.16 | -781.03 | -1,069.42 | -456.63 | -36.68 | 34.09 | 80.82 | 33.17 | 11.32 | 16.10 | 11.31 | 11.35 | |
| EBITDA | -120.00 | -47.00 | 101.00 | -105.00 | -198.00 | -212.00 | -119.00 | -22.00 | 167.00 | 452.00 | 369.00 | 110.00 | 286.00 | 201.00 | 196.00 | |
| EBITDA Margin | -79.33 | -25.92 | 34.92 | -222.47 | -632.71 | -846.33 | -322.73 | -11.67 | 36.96 | 52.95 | 38.18 | 11.14 | 19.98 | 12.51 | 10.74 | |
| Operating Income | -121.00 | -91.00 | 89.00 | -122.00 | -200.00 | -224.00 | -121.00 | -28.00 | 165.00 | 438.00 | 369.00 | 110.00 | 286.00 | 201.00 | 170.00 | |
| Operating Margin | -80.33 | -49.39 | 30.91 | -258.03 | -640.54 | -893.86 | -326.65 | -14.69 | 36.67 | 51.40 | 38.18 | 11.14 | 19.98 | 12.51 | 9.34 | |
| Interest Income | 1.00 | - - | 1.00 | 1.00 | 1.00 | 4.00 | - - | 4.00 | 4.00 | 12.00 | 27.00 | 19.00 | 7.00 | 33.00 | 86.00 | |
| Loss | -273.00 | -243.00 | -189.00 | -160.00 | -230.00 | -241.00 | -157.00 | -218.00 | -286.00 | -414.00 | -598.00 | -877.00 | -1,148.00 | -1,409.00 | -1,659.00 | |
| Cost of Revenue | - - | - - | - - | - - | -1.00 | -2.00 | -3.00 | -6.00 | -15.00 | -26.00 | -33.00 | -36.00 | -52.00 | -57.00 | -72.00 | |
|
Operating Expenses
|
-273.00 | -243.00 | -189.00 | -160.00 | -229.00 | -239.00 | -153.00 | -212.00 | -271.00 | -388.00 | -565.00 | -841.00 | -1,095.00 | -1,351.00 | -1,586.00 | |
| R&D | -234.00 | -210.00 | -156.00 | -128.00 | -178.00 | -189.00 | -96.00 | -95.00 | -112.00 | -182.00 | -336.00 | -547.00 | -693.00 | -891.00 | -1,044.00 | |
| G&A | - - | -33.00 | -33.00 | -31.00 | -50.00 | -50.00 | -57.00 | -116.00 | -159.00 | -206.00 | -210.00 | -268.00 | -369.00 | -418.00 | -502.00 | |
| SG&A | -38.00 | -33.00 | -33.00 | -31.00 | -50.00 | -50.00 | -57.00 | -116.00 | -159.00 | -206.00 | -228.00 | -293.00 | -401.00 | -459.00 | -542.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | -8.00 | -14.00 | -17.00 | -25.00 | -31.00 | -41.00 | -40.00 | |
| Depreciation and Amortization | -12.00 | -10.00 | -6.00 | -5.00 | -3.00 | -2.00 | -1.00 | -1.00 | -1.00 | -7.00 | -8.00 | -9.00 | -13.00 | -20.00 | -25.00 | |
| Interest Expenses | -12.00 | -9.00 | -16.00 | -27.00 | -45.00 | -48.00 | -48.00 | -33.00 | -8.00 | - - | - - | - - | - - | -53.00 | - - | |
| Other Expenses | -7.00 | -24.00 | -7.00 | -9.00 | -1.00 | -7.00 | -1.00 | -14.00 | -3.00 | - - | -28.00 | -20.00 | -7.00 | -32.00 | - - | |
|
WA Shares Outstanding
|
107.00 | 108.00 | 126.00 | 160.00 | 184.00 | 194.00 | 209.00 | 250.00 | 293.00 | 297.00 | 302.00 | 308.00 | 314.00 | 321.00 | 318.00 | |
| Diluted | 107.00 | 108.00 | 130.00 | 160.00 | 184.00 | 194.00 | 209.00 | 250.00 | 312.00 | 312.00 | 315.00 | 318.00 | 322.00 | 324.00 | 321.00 |